0001493152-24-011570.txt : 20240327
0001493152-24-011570.hdr.sgml : 20240327
20240327175331
ACCESSION NUMBER: 0001493152-24-011570
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240325
FILED AS OF DATE: 20240327
DATE AS OF CHANGE: 20240327
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Del Giudice Matthew Paul
CENTRAL INDEX KEY: 0002016630
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41765
FILM NUMBER: 24792391
MAIL ADDRESS:
STREET 1: MIRA PHARMACEUTICALS, INC.
STREET 2: 1200 BRICKELL AVENUE, SUITE 1950 #1183
CITY: MIAMI
STATE: FL
ZIP: 33131
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MIRA PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001904286
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 853354547
STATE OF INCORPORATION: FL
BUSINESS ADDRESS:
STREET 1: 1200 BRICKELL AVENUE
STREET 2: SUITE 1950 #1183
CITY: MIAMI
STATE: FL
ZIP: 33131
BUSINESS PHONE: 813-369-5150
MAIL ADDRESS:
STREET 1: 324 SOUTH HYDE PARK AVENUE, SUITE 350
CITY: TAMPA
STATE: FL
ZIP: 33606
FORMER COMPANY:
FORMER CONFORMED NAME: Mira1a Therapeutics, Inc.
DATE OF NAME CHANGE: 20220112
4
1
ownership.xml
X0508
4
2024-03-25
0
0001904286
MIRA PHARMACEUTICALS, INC.
MIRA
0002016630
Del Giudice Matthew Paul
C/O MIRA PHARMACEUTICALS, INC.
1200 BRICKELL AVENUE, SUITE 1950 #1183
MIAMI
FL
33131
1
0
0
0
0
Nonqualified Stock Option (right to buy)
1.16
2024-03-25
4
A
0
50000
0
A
2034-03-25
Common Stock
50000
25000
D
The options were granted under the Issuer's 2022 Omnibus Incentive Plan whereby 50% of such options, or 25,000 options, vested immediately on the grant date of March 25, 2024, and the remaining 50% vest on the first anniversary of the grant date, March 25, 2025.
/s/ Matthew Del Giudice
2024-03-27